FDA Consumer

View more issues:

Articles in Sept, 1996 issue of FDA Consumer

• Colon and rectal cancer drug - Food and Drug Administration approves Camptosar, or irinotecan - Brief Article
• Outsmarting poison ivy and its cousins - includes related articles on plant removal, herbicides and plant identification
  by Isadora B. Stehlin
• Stroke treatment approved - Food and Drug Administration approves Activase, or alteplase - Brief Article
• How folate can help prevent birth defects - includes list of information sources - Cover Story
  by Paula Kurtzweil
• Second breast cancer drug from yew tree - Food and Drug Administration approves Taxotere, or docetaxel - Brief Article
• Hair today, gone tomorrow - removing unwanted hair
  by Marian Segal
• Added use for heart device approved in six days - Food and Drug Administration approves Guidant implantable defibrillator for asymptomatic ventricular arrhythmia - Brief Article
• Unrealistic claims for eye surgery concern FDA, FTC - photorefractive keratectomy, Food and Drug Administration, Federal Trade Commission - Brief Article
• Test predicts risk of HIV progression - Amplicor HIV-1 Monitor Test
• Glimmer of hope for people with ALS - amyotrophic lateral sclerosis - includes related article on physicist and ALS patient Stephen W. Hawking
  by Eleanor L. Mayfield
• First drug for rare parasitic diseases - Food and Drug Administration approves Albenza, or albendazole, for treating neurocysticercosis and hydatid disease - Brief Article
• A 'washed-up' snake-oil scheme - Lawrence Taylor and William Stacey on trial for offering unapproved cancer treatment - Investigators' Reports
  by Paula Kurtzweil
• Treatment slows MS - Food and Drug Administration licenses Avonex, or interferon beta-1a, an injectable multiple sclerosis treatment - Brief Article
• Unproven medical claims land men in prison - Pascal Ballistrea, Michael Ricotta, Brian Strandberg - Investigators' Reports
  by Dixie Farley
• New type of drug for ovarian cancer - Food and Drug Administration approves Hycamtin, or topotecan - Brief Article
• Boning up on osteoporosis - includes list of information sources and related articles on calcium intake and risk factors for osteoporosis
  by Carolyn J. Strange
• Glaucoma drug approved for some patients - Food and Drug Administration approves eye drop Xalatan, or latanoprost, for use in patients who cannot tolerate other treatments - Brief Article
• Importer convicted of attempted bribery - Bernard Kwang Myung - Investigators' Reports
  by Herman Janiger
• Device to lessen incontinence - Food and Drug Administration approves Miniguard disposable foam pad for women - Brief Article
• Violations uncovered at Army blood center - Walter Reed Army Medical Center - Investigators' Reports
  by Dori Stehlin